Non-specific immunological effects of selected routine childhood immunisations: systematic review

R Kandasamy, M Voysey, F McQuaid, K de Nie… - bmj, 2016 - bmj.com
Objective To identify and characterise non-specific immunological effects after routine childhood
vaccines against BCG, measles, diphtheria, pertussis, and tetanus. Design Systematic …

Rosetting revisited: a critical look at the evidence for host erythrocyte receptors in Plasmodium falciparum rosetting

F McQuaid, JA Rowe - Parasitology, 2020 - cambridge.org
Malaria remains a major cause of mortality in African children, with no adjunctive treatments
currently available to ameliorate the severe clinical forms of the disease. Rosetting, the …

[HTML][HTML] Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data

F McQuaid, R Mulholland, Y Sangpang Rai… - PLoS …, 2022 - journals.plos.org
Background In 2020, the SARS-CoV-2 (COVID-19) pandemic and lockdown control measures
threatened to disrupt routine childhood immunisation programmes with early reports …

[HTML][HTML] Factors influencing women's attitudes towards antenatal vaccines, group B Streptococcus and clinical trial participation in pregnancy: an online survey

F McQuaid, C Jones, Z Stevens, J Plumb, R Hughes… - BMJ open, 2016 - bmjopen.bmj.com
Objectives To explore factors influencing the likelihood of antenatal vaccine acceptance of
both routine UK antenatal vaccines (influenza and pertussis) and a hypothetical group B …

Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age

F McQuaid, MD Snape, TM John, S Kelly… - The Pediatric …, 2014 - journals.lww.com
Background: A serogroup B meningococcal vaccine (4CMenB) has been licensed by the
European commission for use in various infant schedules. However, data are limited on …

Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months

F McQuaid, MD Snape, TM John, S Kelly, H Robinson… - Cmaj, 2015 - Can Med Assoc
Background: The multicomponent serogroup B meningococcal (4CMenB) vaccine induces
antibodies against indicator strains of serogroup B meningococcus under various schedules. …

Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and …

F McQuaid, C Jones, Z Stevens… - Acta obstetricia et …, 2018 - Wiley Online Library
Introduction Maternal vaccination is increasingly part of antenatal care in the UK and
worldwide. Trials of Group B streptococcus vaccines are ongoing. This study investigated the …

Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare …

F McQuaid, S Pask, L Locock, E Davis, Z Stevens… - Vaccine, 2016 - Elsevier
Introduction Antenatal vaccination has become a part of routine care during pregnancy in
the UK and worldwide, leading to improvements in health for both pregnant women and their …

Attitudes towards vaccination against group B streptococcus in pregnancy

F McQuaid, C Jones, Z Stevens, J Plumb… - Archives of disease in …, 2014 - adc.bmj.com
Group B streptococcus (GBS) is the commonest cause of sepsis and meningitis in the
neonatal period in the UK with case numbers similar to that of meningococcal disease in older …

Confirmed SARS-CoV-2 infection in Scottish neonates 2020–2022: a national, population-based cohort study

A Goulding, F McQuaid, L Lindsay, U Agrawal… - Archives of Disease in …, 2023 - fn.bmj.com
Objectives To examine neonates in Scotland aged 0–27 days with SARS-CoV-2 infection
confirmed by viral testing; the risk of confirmed neonatal infection by maternal and infant …